Anti-DLL4, a cancer therapeutic with multiple mechanisms of action

Vascular Cell

Volumn 3, Issue , 2011, Pages

  Gurney, Austin ^a   Hoey, Timothy ^a  

^a OncoMed Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; DELTA LIKE LIGAND 4 ANTIBODY; LIGAND; NOTCH RECEPTOR; OMP 21M18; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER STEM CELL; CANCER THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 84858248356     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-3-18     Document Type: Review

References (44)

1. The cancer stem cell: premises, promises and challenges. Clevers H, Nat Med 2011 17 313 319 21386835
2. Cancer stem cells and self-renewal. O'Brien CA, Kreso A, Jamieson CH, Clin Cancer Res 2010 16 3113 3120 10.1158/1078-0432.CCR-09-2824 20530701
3. Self-renewal and solid-tumor stem cells. Clarke MF, Biol Blood Marrow Transplant 2005 11 14 16 15682169 (Pubitemid 40186218)
4. Crypt stem cells as the cells-of-origin of intestinal cancer. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H, Nature 2009 457 608 611 10.1038/nature07602 19092804
5. Novel insights into the differential functions of Notch ligands in vascular formation. Kume T, J Angiogenes Res 2009 1 8 10.1186/2040-2384-1-8 20016694
6. Notch signaling in the vasculature. Gridley T, Curr Top Dev Biol 2010 92 277 309 20816399
7. Regulation of vascular morphogenesis by Notch signaling. Roca C, Adams RH, Genes Dev 2007 21 2511 2524 10.1101/gad.1589207 17938237 (Pubitemid 47607663)
8. Notch signaling in blood vessels: who is talking to whom about what? Hofmann JJ, Iruela-Arispe ML, Circ Res 2007 100 1556 1568 10.1161/01.RES. 0000266408.42939.e4 17556669 (Pubitemid 46897259)
9. Notch3 is critical for proper angiogenesis and mural cell investment. Liu H, Zhang W, Kennard S, Caldwell RB, Lilly B, Circ Res 2010 107 860 870 10.1161/CIRCRESAHA.110.218271 20689064
10. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Liu H, Kennard S, Lilly B, Circ Res 2009 104 466 475 10.1161/CIRCRESAHA.108.184846 19150886
11. Building a vessel wall with notch signaling. Regan JN, Majesky MW, Circ Res 2009 104 419 421 10.1161/CIRCRESAHA.109.194233 19246684
12. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Dufraine J, Funahashi Y, Kitajewski J, Oncogene 2008 27 5132 5137 10.1038/onc.2008.227 18758482
13. Bone marrow-derived endothelial progenitors expressing delta-like 4 (dll4) regulate tumor angiogenesis. Real C, Remedio L, Caiado F, Igreja C, Borges C, Trindade A, Pinto-do OP, Yagita H, Duarte A, Dias S, PLoS One 2011 6 18323 10.1371/journal.pone.0018323 21483741
14. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, Gadient R, Jacobs RT, Zacco A, Greenberg B, Ciaccio PJ, Toxicol Sci 2004 82 341 358 10.1093/toxsci/kfh254 15319485 (Pubitemid 39485346)
15. Therapeutic potential of gamma-secretase inhibitors and modulators. Imbimbo BP, Curr Top Med Chem 2008 8 54 61 10.2174/156802608783334015 18220933 (Pubitemid 351791047)
16. Substrate specificity of gamma-secretase and other intramembrane proteases. Beel AJ, Sanders CR, Cell Mol Life Sci 2008 65 1311 1334 10.1007/s00018-008-7462-2 18239854
17. Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. Hemming ML, Elias JE, Gygi SP, Selkoe DJ, PLoS Biol 2008 6 257 10.1371/journal.pbio.0060257 18942891
18. Notch signalling: a simple pathway becomes complex. Bray SJ, Nat Rev Mol Cell Biol 2006 7 678 689 10.1038/nrm2009 16921404 (Pubitemid 44268213)
19. Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles. Benedito R, Duarte A, Gene Expr Patterns 2005 5 750 755 10.1016/j.modgep.2005.04.004 15923152 (Pubitemid 40945859)
20. Dosage-sensitive requirement for mouse Dll4 in artery development. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J, Genes Dev 2004 18 2474 2478 10.1101/gad.1239004 15466159 (Pubitemid 39362889)
21. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, et al. Proc Natl Acad Sci USA 2004 101 15949 15954 10.1073/pnas.0407290101 15520367 (Pubitemid 39507907)
22. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T, Genes Dev 2004 18 2469 2473 10.1101/gad.1239204 15466160 (Pubitemid 39362888)
23. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. Koch U, Fiorini E, Benedito R, Besseyrias V, Schuster-Gossler K, Pierres M, Manley NR, Duarte A, Macdonald HR, Radtke F, J Exp Med 2008 205 2515 2523 10.1084/jem.20080829 18824585
24. Delta-like 4 is indispensable in thymic environment specific for T cell development. Hozumi K, Mailhos C, Negishi N, Hirano K, Yahata T, Ando K, Zuklys S, Hollander GA, Shima DT, Habu S, J Exp Med 2008 205 2507 2513 10.1084/jem.20080134 18824583
25. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, Chensue SW, Kunkel SL, J Clin Invest 2009 119 33 46 19075396
26. Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. Kassner N, Krueger M, Yagita H, Dzionek A, Hutloff A, Kroczek R, Scheffold A, Rutz S, J Immunol 2010 184 550 554 10.4049/jimmunol.0903152 20008296
27. Delta-Like Ligand 4 Regulates CNS T Cell Accumulation during Experimental Autoimmune Encephalomyelitis. Reynolds ND, Lukacs NW, Long N, Karpus WJ, J Immunol 2011
28. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, Espinosa L, Kaestner KH, Kopan R, Lewis J, Radtke F, Gastroenterology 2011 140 1230 1240 e1237 10.1053/j.gastro.2011.01.005 21238454
29. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, et al. Nature 2006 444 1083 1087 10.1038/nature05313 17183323 (Pubitemid 46018529)
30. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G, Nature 2006 444 1032 1037 10.1038/nature05355 17183313 (Pubitemid 46018516)
31. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, et al. Cell Stem Cell 2009 5 168 177 10.1016/j.stem.2009.05.019 19664991
32. VEGF inhibition: insights from preclinical and clinical studies. Crawford Y, Ferrara N, Cell Tissue Res 2009 335 261 269 10.1007/s00441-008-0675-8 18766380
33. VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future. Sharma PS, Sharma R, Tyagi T, Curr Cancer Drug Targets 2011
34. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N, et al. Nature 2007 445 776 780 10.1038/nature05571 17259973 (Pubitemid 46279716)
35. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J, Vasc Cell 2011 3 2 10.1186/2045-824X-3-2 21349159
36. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G, Clin Cancer Res 2009 15 2291 2301 10.1158/1078-0432.CCR-08-2004 19258443
37. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, et al. Cancer Res 2009 69 1314 1323 10.1158/0008-5472.CAN-08-2791 19208840
38. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Martinez JC, Muller MM, Turley H, Steers G, Choteau L, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC, Histopathology 2009 54 598 606 10.1111/j.1365-2559.2009.03279.x 19413639
39. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H, Nature 2011 469 415 418 10.1038/nature09637 21113151
40. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Fischer M, Yen WC, Kapoun AM, Wang M, O'Young G, Lewicki J, Gurney A, Hoey T, Cancer Res 2011 71 1520 1525 10.1158/0008-5472.CAN-10-2817 21193546
41. Chronic DLL4 blockade induces vascular neoplasms. Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, Niessen K, Plowman GD, Nature 2010 463 6 7 10.1038/nature08751 20147986
42. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A, BMC Cancer 2010 10 641 10.1186/1471-2407-10-641 21092311
43. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino G, Callahan R, Genes Dev 1992 6 345 355 10.1101/gad.6.3.345 1372276
44. A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. Gallahan D, Kozak C, Callahan R, J Virol 1987 61 218 220 3023699 (Pubitemid 17212466)